Cargando…

FDA's pathway for regulation of FMT: not so fraught

Detalles Bibliográficos
Autores principales:	Riley, Margaret F., Olle, Bernat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Peer Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034401/ https://www.ncbi.nlm.nih.gov/pubmed/27774226 http://dx.doi.org/10.1093/jlb/lsv046

Ejemplares similares

Can the COVID-19 interstate travel restrictions help lift the FDA’s blood ban?
por: Dorfman, Doron
Publicado: (2020)

Alcohol Abuse and Alcoholic Liver Cirrhosis Leading to Spontaneous Muscle Hematoma: An Event Fraught with Danger
por: Mangla, Ankit, et al.
Publicado: (2015)

Regulation of cognitive enhancement devices: commentary
por: Johnson, Reuben, et al.
Publicado: (2014)

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

As anonymity disappears the focus becomes limits on donor offspring
por: Nelson, Margaret K., et al.
Publicado: (2016)

Two kinds of rule regulating human subjects research
por: Sachs, Benjamin
Publicado: (2015)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

Buttressing regulation of cognitive enhancement devices with principles of harm reduction
por: Fitz, Nicholas S., et al.
Publicado: (2014)

Modernizing biomedical regulation: foresight and values in the promotion of responsible research and innovation
por: Harmon, Shawn H.E.
Publicado: (2016)

Regulating drug promotion to promote the public health: a response to Bennett et al.
por: Zettler, Patricia J.
Publicado: (2015)

First, do no harm: the proposed definition of “terminal anorexia” is fraught with danger for vulnerable individuals
por: Riddle, Megan, et al.
Publicado: (2022)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

Egg freezing, stratified reproduction and the logic of not
por: Ikemoto, Lisa C.
Publicado: (2015)

‘Good soldiers are made, not born’(⊥): the dangers of medicalizing ability in the military use of genetics
por: Roberts, Jessica L.
Publicado: (2015)

The most plausible pro-coercion view: requiring informed agreement while penalizing non-participation in research
por: Barnhill, Anne
Publicado: (2015)

Informed consent to participation in interventional studies: second-order in a different sense
por: Eyal, Nir
Publicado: (2015)

Are ethics promulgations self-defeating?
por: Gray, Derrick
Publicado: (2015)

Diversion effects, incentive effects, and the goals of research ethics promulgations
por: Wenner, Danielle M.
Publicado: (2015)

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

The problems of liminal states, line drawing, and false dichotomies
por: Suter, Sonia
Publicado: (2015)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

The mouse that trolled
por: Hardy, John
Publicado: (2015)

Universities and Patent Demands
por: Cordova, Andrew K., et al.
Publicado: (2015)

It depends whose data are being shared: considerations for genomic data sharing policies
por: Robinson, Jill O., et al.
Publicado: (2015)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Environmental neuroethics: changing the environment—changing the brain Recommendations submitted to the Presidential Commission for the Study of Bioethical Issues
por: Illes, Judy, et al.
Publicado: (2014)

Law and neuroscience: recommendations submitted to the President's Bioethics Commission
por: Jones, Owen D., et al.
Publicado: (2014)

Letter
Publicado: (2014)

Ethical considerations of neuroscience research and the application of neuroscience research findings for the Presidential Commission for the Study of Bioethical Issues
Publicado: (2014)

Considering advances in neuroscience through the lenses of law and human rights
por: Frankel, Mark S.
Publicado: (2014)

Yesterday's war; tomorrow's technology: peer commentary on ‘Ethical, legal, social and policy issues in the use of genomic technologies by the US military’
por: Evans, Nicholas G., et al.
Publicado: (2014)

Military genomic testing: proportionality, expected benefits, and the connection between genotypes and phenotypes
por: Pence, Charles H.
Publicado: (2014)

What do experimental simulations tell us about the effect of neuro/genetic evidence on jurors?
por: Scurich, Nicholas
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hp3dc5hudba978uoisc651jn08